☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Diffuse Large B Cell Lymphoma
Roche's Polivy (polatuzumab vedotin) Receives Health Canada's Approval For R/R Diffuse Large B Cell Lymphoma
September 25, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.